YK-11 (Myostine) Capsules
€ 39,95
YK-11 capsules, also identified as Myostine, contain a synthetic steroidal androgen-receptor research compound presented by Raw Lab Chems with seller-specified ≥99% purity. The material is intended exclusively for controlled in-vitro, analytical, and laboratory research.
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
YK-11 (Myostine) Capsules
Product Overview
YK-11 capsules, also identified as Myostine or YK11, provide a formulated presentation of a synthetic steroidal research compound investigated primarily in connection with androgen-receptor signaling and related molecular pathways. The compound is commonly discussed in research literature as a steroidal selective androgen receptor modulator (SARM) and gene-selective partial androgen-receptor agonist.
Raw Lab Chems presents the material exclusively for controlled laboratory, in-vitro, and analytical research. The supplied specification states ≥99% purity. This is treated as a seller-provided specification rather than independent verification.
Experimental literature surrounding YK-11 has included investigation of androgen-receptor activity, follistatin expression, myogenic regulatory pathways, and comparisons between steroidal and nonsteroidal receptor ligands. These subjects establish a scientific context for the compound but do not establish therapeutic, athletic, bodybuilding, or other personal-use applications.
Because much of the research associated with YK-11 is preclinical or cell-based, experimental observations should not be extrapolated into claims about outcomes in humans or animals.
Chemical Identity & Classification
YK-11 is also known as Myostine and YK11. The supplied molecular formula is C25H34O6.
The supplied chemical description identifies the compound as (17α,20E)-17,20-[(1-methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic acid methyl ester.
This nomenclature reflects the steroidal structural framework associated with YK-11. The compound is commonly classified in research contexts as a steroidal SARM and androgen-receptor ligand. References to myostatin inhibition in the supplied material relate to experimental investigation of follistatin-associated pathways rather than a separate verified product classification.
Researchers can consult PubChem when reviewing chemical identifiers and general reference information, while ensuring that the selected record corresponds precisely to the material being investigated.
Chemical identity should be documented independently from the capsule formulation because excipients or other formulation components are not defined by the molecular formula of YK-11 itself.
Chemical & Physical Characteristics
The product is supplied in capsule form containing formulated research material. No verified information was supplied concerning capsule color, shell composition, dimensions, excipient composition, fill appearance, or other formulation-specific physical characteristics.
The molecular formula supplied for the underlying YK-11 compound is C25H34O6. Its steroidal framework differentiates it structurally from many nonsteroidal compounds grouped within the broader SARM research category.
The supplied information recommends storage in a cool, dry environment protected from direct sunlight and moisture. These conditions provide general storage context, but no Raw Lab Chems stability study or validated shelf-life dataset was supplied.
Researchers should distinguish properties of isolated YK-11 from characteristics of the complete capsule formulation. Matrix components can influence analytical extraction, chromatography, sample behavior, and other observations during formulation-focused laboratory investigation.
Purity & Analytical Verification
The supplied specification for YK-11 capsules is ≥99% purity for the research compound.
The source additionally states that HPLC is used to assess purity and that mass spectrometry and proton NMR are used for structural characterization. These are retained as supplied quality statements but should not be interpreted as independently verified analytical results in the absence of batch-specific supporting documentation.
HPLC, LC-MS, GC-MS, NMR, and related analytical methods can be relevant to YK-11 characterization when appropriately validated for the research objective. Different techniques can address distinct questions concerning identity, purity, composition, structural characteristics, or formulation behavior.
For capsule-based research, compound purity and formulation uniformity are separate analytical considerations. A purity specification for the active research material does not by itself establish uniform distribution across individual formulated units.
Researchers requiring confirmed analytical values should rely on documentation applicable to the specific batch or perform suitable independent characterization.
Quality Control & Batch Integrity
The supplied information describes analytical quality controls involving HPLC, mass spectrometry, proton NMR, and formulation-homogeneity procedures. No underlying chromatograms, spectra, validation records, or batch-specific reports were supplied with the product information.
Accordingly, Raw Lab Chems’ stated ≥99% purity is presented as seller-specified, while the additional testing statements should be confirmed against documentation for the specific batch when required for research.
Reliable laboratory records can include product identity, supplier, lot information, receipt date, storage history, analytical observations, and formulation details. These records help preserve traceability between the physical material and experimental results.
Capsule uniformity should not be inferred solely from the nominal formulation. When uniformity is an important experimental variable, it should be established through documentation or appropriate analytical assessment applicable to the specific material.
Safety, Handling & Laboratory Precautions
YK-11 should be handled only by appropriately trained laboratory personnel. Suitable personal protective equipment, containment, ventilation, access controls, and waste-management procedures should be determined through institutional risk assessment and applicable safety documentation.
The compound is an experimental research material. Its reported activity in cell-based systems should be considered when establishing laboratory controls, but experimental biological observations do not establish safety, efficacy, or suitability for personal use.
Researchers should consult an applicable Safety Data Sheet and institutional procedures for information concerning accidental exposure, spills, contamination, environmental release, waste collection, and disposal.
The material should be secured against unauthorized access and kept away from children, pets, food, beverages, and non-research environments.
Packaging, Labeling & Storage
The supplied information describes moisture-resistant and light-protective packaging. However, no packaging specification, validation report, or stability dataset was supplied to independently establish these characteristics.
Storage information recommends a cool, dry environment protected from direct sunlight and moisture. Researchers should also follow batch-specific documentation, applicable SDS information, and institutional chemical-storage requirements.
Laboratory labels should preserve the product identity, chemical name, lot information where available, receipt date, and other information required by institutional procedures.
Because the material is formulated in capsules, storage requirements should account for the complete formulation rather than assuming that reference conditions for isolated YK-11 automatically establish validated conditions for the finished research material.
Intended Research Use & Market Positioning
YK-11 is relevant to laboratory investigation of androgen-receptor signaling, gene-selective receptor activity, steroidal ligand chemistry, follistatin-associated pathways, analytical method development, and comparative research involving steroidal and nonsteroidal androgen-receptor ligands.
The supplied material also identifies LC-MS/MS and GC-MS method calibration and validation as potential analytical contexts. Suitability for a particular calibration procedure depends on the analytical method, reference requirements, matrix, and validated laboratory protocol.
Researchers comparing different presentations can separately review Raw Lab Chems YK-11 Powder (Myostine) and MK-677 Powder / Istobal / Nutrobal. These are distinct research materials and should not be considered chemically or analytically interchangeable.
The Raw Lab Chems YK-11 Myostine capsule research listing provides the catalog reference for this formulation.
No medical, therapeutic, diagnostic, veterinary, bodybuilding, muscle-building, athletic-performance, cosmetic, or consumptive application is represented by this description.
Ordering, Availability & Fulfillment
Institutional procurement of YK-11 capsules should begin with confirmation of the required formulation, documentation requirements, institutional authorization, and any jurisdiction-specific restrictions relevant to the proposed research.
The supplied material refers to standard laboratory counts but does not provide verified current inventory or specific package configurations. Availability should therefore not be inferred from the descriptive content.
The source also describes specialized protective packaging and worldwide shipping. These statements are not presented as guaranteed Raw Lab Chems fulfillment terms because no supporting logistics information was supplied.
No claims are made concerning current stock, dispatch schedules, courier services, delivery times, tracking, payment methods, customs processing, or geographic availability.
Researchers and institutions remain responsible for determining whether acquisition, possession, import, export, transfer, storage, and investigation of the material are appropriately authorized.
Legal & Regulatory Disclaimer
For research use only. Not for human or veterinary use. Not for clinical, diagnostic, or consumptive applications.
YK-11 is an experimental research compound. Regulatory treatment may differ by jurisdiction, intended activity, institutional requirements, and applicable sporting, medicines, or chemical-control frameworks.
Researchers and institutions are responsible for determining and complying with requirements governing acquisition, possession, licensing, import, export, transfer, storage, security, research, environmental handling, and disposal.
A research-use designation does not establish universal legality, medical approval, suitability as a dietary supplement, or exemption from anti-doping, medicines, chemical-control, institutional, or other applicable requirements.
You must be logged in to post a review.

Reviews
There are no reviews yet.